Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Biomagnetics Diagnostics Corp.

Sep 2011
Biomagnetics Diagnostics Corp., based in Orangevale, Calif., has accepted delivery of a biosensor that is proposed for use in diagnosing cholera, tuberculosis and malaria. The sensor could be in clinical trials by 2012. Developed in conjunction with scientists and engineers at Los Alamos National Laboratory in New Mexico, the device could allow relatively untrained medical personnel to detect a variety of diseases rapidly. It uses planar waveguides to bring protein-receptor pairs into proximity with one another, thus triggering detectable fluorescence. The company plans to commercialize the sensor, which was created through a cooperative research and development agreement with Los Alamos National Security LLC.

The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
AmericasBiomagnetics Diagnostics Corp.BiophotonicsbiosensorBusinessCaliforniacholeraClayton Hardmanclinical trialsdefensefluorescenceimagingLos Alamos National LaboratoryLos Alamos National Security LLCmalaria diagnosisopticsplanar waveguidesprotein-receptor pairsRapidScanSan FranciscoSensors & Detectorstuberculosis

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!